Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
U.S. Marshals Seize Infusion Pumps At FDA's Request
At the request of the FDA, the U.S. District Court for the Northern District of Illinois issued a warrant on Oct. 12 for seizure of three types of infusion pumps manufactured by Baxter Healthcare Corp. Infusion pumps are electronic devices intended to control delivery of solutions and medications to patients. Pump shutdown could result in serious injuries or death to critically ill patients who depend on continuous infusion medications and/or life-sustaining medications. FDA inspections revealed that the firm had continually failed to follow medical device manufacturing requirements. The FDA alleges that none of the seized infusion pumps were manufactured under the proper controls and that the Colleague pumps have a design defect that may cause the pumps to stop and shut down during infusion therapy. The agency also says Baxter failed to inform it of some of the infusion pump failures.
The seized products are: SYNDEO PCA Syringe Pumps, Colleague Volumetric Infusion Pumps, and Colleague CX Volumetric Infusion Pumps. Baxter has distributed these products worldwide. No products were seized from healthcare facilities or individual users, and there are no plans to do so. Healthcare facilities can continue to use pumps in their possession, guided by instructions Baxter provided previously, but should recognize the types of problems that could occur and have a backup plan in place, especially in situations where the pump is part of a life-saving function. More detailed recommendations for users of specific pump models are available on Baxter's Web site at www.Baxter.com.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
In 1987, a unanimous Court of Appeals reaffirmed the vitality of the "stranger to the deed" rule, which holds that if a grantor executes a deed to a grantee purporting to create an easement in a third party, the easement is invalid. Daniello v. Wagner, decided by the Second Department on November 29th, makes it clear that not all grantors (or their lawyers) have received the Court of Appeals' message, suggesting that the rule needs re-examination.